Venoocclusive Disease is a rare inflammatory condition that causes tiny veins within the liver and heart to become obstructed and destroyed. The disease was first found in individuals who had consumed pyrrolizidine alkaloids, though Venoocclusive Disease is now considered a serious bone marrow transplant complication. Symptoms include jaundice, weight gain, and hepatomegaly. Patients with severe forms of the disease may develop multiple organ failure. There is no specific treatment for Venoocclusive Disease, though those who contracted the disease through hematopoietic stem cell transplantation during a bone marrow transplant should receive fewer transplants.
Venoocclusive Disease Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Venoocclusive Disease below!
For more information on how to use Laverne, please read the How to Guide.
We have 2586 products for the study of Venoocclusive Disease that can be applied to Western Blot, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry from our catalog of antibodies and ELISA kits.
Venoocclusive Disease is also known as Vaso-occlusive Disease, Veno-occlusive Disease, Vod.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.